The majority of grade III meningiomas either show homozygous deletions of p16INK4a,p14ARF, and CDKN2B, mutations in p16INK4a and p14ARF, or lack of expression of one or more of these genes (3). The gene discussed is CDKN2A; the disease is meningioma.